Evidence map›Paper›PMID 30326943›Full record

ArticleJournal of experimental & clinical cancer research : CR2018

Temozolomide-Perillyl alcohol conjugate impairs Mitophagy flux by inducing lysosomal dysfunction in non-small cell lung Cancer cells and sensitizes them to irradiation.

Minghui Chang, Xingguo Song, Xinran Geng, Xingwu Wang, Weijun Wang, Thomas C Chen, Li Xie, Xianrang Song

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Mitophagy Receptors in Tumor Biology.Frontiers in cell and developmental biology · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Minghui ChangSchool of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medicine Science, Jinan, Shandong, People's Republic of China.
Xingguo SongShandong Provincial Key Laboratory of Radiation Oncology, Shandong cancer hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, 440 Ji-Yan Road, Jinan, 250117, Shandong Province, People's Republic of China.
Xinran GengMaternity & Child Care Center of Dezhou, Dongdizhong Street 835#, Decheng District, Dezhou, Shandong, People's Republic of China.
Xingwu WangShandong Provincial Key Laboratory of Radiation Oncology, Shandong cancer hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, 440 Ji-Yan Road, Jinan, 250117, Shandong Province, People's Republic of China.
Weijun WangDepartments of Neurological Surgery, and Pathology, University of Southern California, California, Los Angeles, USA.
Thomas C ChenDepartments of Neurological Surgery, and Pathology, University of Southern California, California, Los Angeles, USA.
Li XieDepartment of Clinical Laboratory, Shandong cancer hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, 440 Ji-Yan Road, Jinan, 250117, Shandong Province, People's Republic of China.
Xianrang SongDepartment of Clinical Laboratory, Shandong cancer hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, 440 Ji-Yan Road, Jinan, 250117, Shandong Province, People's Republic of China. basiclab@163.com.
Neurological Surgery · USShandong First Medical University · CNShandong University · CNUniversity of Jinan · CN

Funding

National Natural Science Foundation of China 81372888National Natural Science Foundation of China 81401916National Natural Science Foundation of China 81502263
6 · The paper itself

Abstract

backgroundTemozolomide-perillyl alcohol conjugate (TMZ-POH), a novel Temozolomide (TMZ) analog developed based on the conjugation of TMZ and perillyl alcohol (POH), displayed strong anticancer potency in multiple cancer types. In this study, we aimed to clarify the relationship between TMZ-POH and autophagy, and explore the underlying mechanisms involved in.

methodsThe proteins involved in autophagy, mitochondrial fission, lysosomal function and membrane traffic were detected by western blots; Autophagosome, mitochondria and lysosome were visualized by transmission electron microscope (TEM) and immunostaining; Apoptosis analysis and fluorescence probe detection were applied by flow cytometry.

resultsTMZ-POH blocked mitophagy flux although the number of autophagosomes which colocalized with mitochondria in the cells was increased via inducing lysosomal dysfunction as evidence from impaired lysosomal acidification, maturation and hampered autophagosome- lysosome fusion, which largely depended on its downregulation on the small GTPase RAB7A via mevalonate pathway. More importantly, our data demonstrated TMZ-POH sensitized cancer cell to irradiation induced apoptosis.

conclusionsTemozolomide-perillyl alcohol conjugate impairs mitophagy flux by inducing lysosomal dysfunction in Non-Small Cell Lung Cancer (NSCLC) cells and sensitizes them to irradiation, thereby proposing TMZ-POH as a potential radiosensitizer.

Indexed as

Antineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungCell Line, TumorHumansLung NeoplasmsLysosomesMitophagyMonoterpenesRadiation-Sensitizing AgentsTemozolomideAntineoplastic Agents, AlkylatingMonoterpenesperillyl alcoholRadiation-Sensitizing AgentsTemozolomideMitophagyNSCLCRAB7ATMZ-POH

Identifiers

PMID30326943
PMCPMC6191917
OpenAlexW2896194057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.